Guillaume Blot

Centre National de la Recherche Scientifique — France

Medicine · Health Sciences

14h-index1.5kcitations58works27.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Retinal Diseases and Treatments(10), HIV Research and Treatment(9), Cancer-related gene regulation(9), Fibroblast Growth Factor Research(6), Kruppel-like factors research(6)

Publications58 total

3D vascularized microtumors unveil aberrant ccRCC vasculature and differential sensitivity to targeted treatments
2025Open Access
DRD2 activation inhibits choroidal neovascularization in patients with Parkinson’s disease and age-related macular degeneration
Journal of Clinical Investigation·2024· 7 citedOpen Access
Therapeutic targeting of cellular senescence in diabetic macular edema: preclinical and phase 1 trial results
Nature Medicine·2024· 75 cited
THERAPEUTIC SENOLYSIS IMPROVES VASCULAR FUNCTION DURING DIABETIC RETINOPATHY
Canadian Journal of Diabetes·2023
THERAPEUTIC SENOLYSIS IMPROVES VASCULAR FUNCTION DURING DIABETIC RETINOPATHY
Canadian Journal of Cardiology·2023
Perilipin 2–positive mononuclear phagocytes accumulate in the diabetic retina and promote PPARγ-dependent vasodegeneration
Journal of Clinical Investigation·2023· 18 citedOpen Access
HIF1α-dependent hypoxia response in myeloid cells requires IRE1α
Journal of Neuroinflammation·2023· 10 citedOpen Access
Data from RASSF1C, an Isoform of the Tumor Suppressor RASSF1A, Promotes the Accumulation of β-Catenin by Interacting with βTrCP
2023Open Access
Supplementary Figure 1 from RASSF1C, an Isoform of the Tumor Suppressor RASSF1A, Promotes the Accumulation of β-Catenin by Interacting with βTrCP
2023Open Access
Supplementary Figure 3 from RASSF1C, an Isoform of the Tumor Suppressor RASSF1A, Promotes the Accumulation of β-Catenin by Interacting with βTrCP
2023Open Access
Supplementary Figure 3 from RASSF1C, an Isoform of the Tumor Suppressor RASSF1A, Promotes the Accumulation of β-Catenin by Interacting with βTrCP
2023Open Access
Data from RASSF1C, an Isoform of the Tumor Suppressor RASSF1A, Promotes the Accumulation of β-Catenin by Interacting with βTrCP
2023Open Access
Supplementary Figure 2 from RASSF1C, an Isoform of the Tumor Suppressor RASSF1A, Promotes the Accumulation of β-Catenin by Interacting with βTrCP
2023Open Access
Supplementary Figure 1 from RASSF1C, an Isoform of the Tumor Suppressor RASSF1A, Promotes the Accumulation of β-Catenin by Interacting with βTrCP
2023Open Access
Supplementary Figure 2 from RASSF1C, an Isoform of the Tumor Suppressor RASSF1A, Promotes the Accumulation of β-Catenin by Interacting with βTrCP
2023Open Access
Past history of obesity triggers persistent epigenetic changes in innate immunity and exacerbates neuroinflammation
Science·2023· 155 cited
Additional file 2 of HIF1α-dependent hypoxia response in myeloid cells requires IRE1α
Figshare·2023Open Access
Additional file 4 of HIF1α-dependent hypoxia response in myeloid cells requires IRE1α
Figshare·2023Open Access
Additional file 3 of HIF1α-dependent hypoxia response in myeloid cells requires IRE1α
Figshare·2023Open Access
Why STAR Protocols authors make excellent protocol reviewers
STAR Protocols·2022· 1 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Richard Benarous(11), Florian Sennlaub(10), Xavier Guillonneau(10), Przemysław Sapieha(9), José‐Alain Sahel(9), Roberto Diaz-Marin(8), Sergio Crespo‐Garcia(8), Ariel M. Wilson(8), Emilie Estrabaud(8), Irina Lassot(8), Erwann Le Rouzic(8), Valérie Tanchou(8), Éric Quéméneur(8), Laurent Daviet(8), Florence Margottin-Goguet(8), Clarisse Berlioz‐Torrent(7), Rachel Juneau(6), Agnieszka Dejda(6), Aude Couturier(6), Lucile Vignaud(6)